Immupharma (IMM)

Company name:Immupharma Plc
EPIC:IMMTrading Currency:GBX
Market Sector:ASM6ISIN:GB0033711010
Market Segment:AMSMShare Type:DE
WWW Address: 10P
 Price Price Change [%] Bid Offer Open High Low Volume
 22.00 1.0 [4.76] 21.10 22.90 21.05 22.95 21.00 1,691,095
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 36.82 167.36 0.03 -5.19 - - - 32.00 - 6.91

Immupharma Key Figures

(at previous day's close)
Market Cap.36.82m
Shares In Issue167.36m
Prev. Close21.00
PE Ratio- 
Dividend Yield-%
EPS - basic-5.19p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-2.82p
Return On Equity (ROE)-94.54%
Operating Margin-9,787.23%
PEG Factor- 
EPS Growth Rate-9.26%
Dividends PS Growth Rate-%
Net Debt-3.88m
Gross Gearing11.95%
Quick Assets6.01m
Net Working Capital5.00m
Intangibles / Fixed Assets18.24%
Turnover PS0.05p
Pre-Tax Profit PS-4.75p
Retained Profit PS-4.31p
Cash PS2.93p
Net Cash PS2.33p
Net Tangible Asset Value PS *4.27p
Net Asset Value PS4.55p
Spread1.80 (7.86%) 

Immupharma Balance Sheet


Share Price Performance

Sample Period HighLow
1 week32.0018.50
4 weeks32.006.91
12 weeks32.006.91
1 year32.006.91

Share Price Chart (5 years)

Immupharma Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week29.80-7.80-26.1718.506.3121.11
4 weeks8.8913.11147.476.913.6123.34
12 weeks9.6112.39128.936.911.4520.68
26 weeks16.605.4032.536.911.0317.68
1 year12.0010.0083.336.910.8215.81
3 years38.13-16.13-42.306.910.9246.19
5 years54.50-32.50-59.636.910.6145.35

Immupharma Key Management Ratios

Immupharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 5.38 
Tobin's Q Ratio (excl. intangibles)5.79 
Dividend Yield-%
Market-to-Book Ratio4.83 
Price-to-Pre-Tax Profit PS-4.63 
Price-to-Retained Profit PS-5.11 
Price-to-Cash Flow PS-7.80 
Price-to-Sales PS452.99 
Price-to-Net Tangible Asset Value PS5.16 
Price-to-Cash PS7.50 
Net Working Capital PS2.99 
Price Pct to Working Capital PS7.37%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Immupharma Financial Ratios

(Leverage Ratios)
Debt Ratio0.29%
Debt-to-Equity Ratio0.00 
Debt-to-Equity Ratio (excl. Intgbl)0.00 
Debt-to-Equity Market Value0.00 
Net Gearing-44.78%
Net Gearing (excl. Intangibles)-47.42%
Gross Gearing11.95%
Gross Gearing (excl. Intangibles)12.66%
Gearing Under 1 Year11.69%
Gearing Under 1 Year (excl. Intgbl)12.38%
(Liquidity Ratios)
Net Working Capital to Total Assets57.73%
Current Ratio5.94 
Quick Ratio (Acid Test)5.94 
Liquidity Ratio4.85 
Cash & Equiv/Current Assets81.72%
(Solvency Ratios)
Enterprise Value31.93m
CFO/Attributable Profit- 
Total Debt/Equity Market Value0.03 
Total Debt/Sales12.73 
Total Debt/Pre-Tax Profit-0.13 
Total Debt1.03m
Total Debt/Net Current Assets0.21%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth-%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs9 
Beta (60-Mnth)Beta (36-Mnth)

Immupharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-104.05%
Return On Assets (ROA)-105.40%
Net Profit Margin-8,866.22%
Assets Turnover0.01 
Return On Equity (ROE)-94.54%
Return On Investment (ROI)-124.97%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-8,866.22%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.01 
Fixed Assets Turnover0.05 
Current Assets Turnover0.02 
Net Working Capital Turnover 
Inventory Turnover- 
(Other Operating Ratios)
Total Assets-to-Sales84.12 
Debt Collection Period6,158.26Days

Immupharma Dividends

Sorry No Data Available

Immupharma Fundamentals

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
pre tax profit-4.55--6.31--7.00--7.96-m
attributable profit-3.90--5.32--6.22--7.21-m
retained profit-3.90--5.32--6.22--7.21-m
eps - basic (p)-4.40 -4.54 -4.75 -5.19 
eps - diluted (p)-4.40 -4.54 -4.75 -5.19 
dividends per share- - - - 

Immupharma Balance Sheet

 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
 31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
fixed assets fixed assets0.288.72%0.233.46%0.163.22%0.161.90%m
intangibles intangibles0.5216.26%0.517.62%0.489.61%0.485.58%m
fixed investments fixed investments--%1.5523.17%--%2.0023.10%m
current assets - other current assets - other--%--%--%--%m
stocks stocks--%--%--%--%m
debtors debtors1.5849.08%2.5437.78%1.6432.77%1.1012.69%m
cash & securities cash & securities0.8325.94%1.8827.97%2.7354.40%4.9156.73%m
creditors - short creditors - short1.2438.65%0.9414.07%1.1322.51%1.0111.69%m
creditors - long creditors - long0.288.74%0.223.27%0.316.24%0.020.26%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
ord cap, reserves ord cap, reserves1.6952.61%5.5582.66%3.5771.24%7.6288.05%m
prefs, minorities prefs, minorities--%--%--%--%m
NAV Basic- - - - 
NAV Diluted- - - - 

Immupharma Cash Flow Statement

31 Dec 2015 (GBP)31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)
Operating CF-4.15-6.49-4.42-4.72m
Pre-Financing CF-4.16-6.49-4.45-6.81m
Retained CF-4.470.900.952.34m

Immupharma Brokers

Panmure Gordon (UK) LimitedMarket Maker(MME)Broker/DealerPMURPMURGB2L
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191207 07:41:41